CVS Health has said it will remove AbbVie’s big-selling immunology drug Humira from most of its national formulary lists of reimbursable products, and offer biosimilar ver
CVS Health has made a move on the US biosimilars category with the launch of Cordavis, a new business unit that will work with other drugmakers to bring private-label bios
CVS Health has decided to shut down its clinical trials business, just two years after launching it to great fanfare in the midst of the COVID-19 pandemic.
CVS Health and Walgreens have become the first two US pharmacy chains to agree a settlement worth nearly $10 billion to answer allegations they played a role in the opioid epidemic that has
Pharmacy chain CVS has stepped up its drive into the wider healthcare market with an agreement to buy at-home care and technology provider Signify Health for around $8 billion – reportedly
It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.